Update on Non-Alcoholic Steatohepatitis, An Issue of Clinics in Liver Disease by Younossi, Zobair M.;

Sorozatcím: The Clinics: Internal Medicine; 27-2;

20% KEDVEZMÉNY?
A kedvezmény csak az 'Értesítés a kedvenc témákról' hírlevelünk címzettjeinek rendeléseire érvényes.

Kiadói listaár EUR 86.99
Az ár azért becsült, mert a rendelés pillanatában nem lehet pontosan tudni, hogy a beérkezéskor milyen lesz a forint árfolyama az adott termék eredeti devizájához képest. Ha a forint romlana, kissé többet, ha javulna, kissé kevesebbet kell majd fizetnie.

36 079 Ft (34 361 Ft + 5% áfa)
Kedvezmény(ek) 20% (cc. 7 216 Ft off)
Kedvezményes ár 28 863 Ft (27 489 Ft + 5% áfa)
A kedvezmény érvényes eddig: 2025. december 31.

36 079 Ft

Beszerezhetőség

Megrendelésre a kiadó utánnyomja a könyvet. Rendelhető, de a szokásosnál kicsit lassabban érkezik meg.

A termék adatai:

Kiadó Elsevier Health Sciences
Megjelenés dátuma 2023. április 12.

ISBN 9780323960564
Kötéstípus Keménykötés
Terjedelem240 oldal
Méret 228x152 mm
Súly 450 g
Nyelv angol

Kategóriák

Hepatológia, májbetegségek Gasztroenterológia Hepatológia, májbetegségek (karitatív célú kampány) Gasztroenterológia (karitatív célú kampány)

Hosszú leírás:

In this issue, guest editors bring their considerable expertise to this important topic.

Contains 20 practice-oriented topics, including metabolic syndrome associated with NASH; genetic markers and comorbidities predisposing to NASH and progressive liver disease; the role of bariatric surgery and endobariatric surgery in NASH; future treatment options and regimens for NAFLD; and more.ï¿1⁄2
Provides in-depth clinical reviews on non-alcoholic steatohepatitis, offering actionable insights for clinical practice.ï¿1⁄2
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.ï¿1⁄2

Több

Tartalomjegyzék:

Nonalcoholic Fatty Liver Disease: Disease Burden and Disease Awareness
Metabolic Syndrome and Its Association with Nonalcoholic Steatohepatitis
Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma
Changings and Challenges in Liver Transplantation for Nonalcoholic Fatty Liver Disease/Steatohepatitis
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Cardiovascular Diseases
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Nonhepatocellular Cancers
Update on Nonalcoholic Steatohepatitis: Sarcopenia and Nonalcoholic Fatty Liver Disease
Nonalcoholic Fatty Liver Disease in Asia, Africa, and Middle East Region
Nonalcoholic Fatty Liver Disease in Latin America and Australia
Pathogenetic Pathways in Nonalcoholic Fatty Liver Disease: An Incomplete Jigsaw Puzzle
Genetic Markers Predisposing to Nonalcoholic Steatohepatitis
Role of Liver Biopsy in Clinical Trials and Clinical Management of Nonalcoholic Fatty Liver Disease
Roles of Radiological Tests in Clinical Trials and the Clinical Management of Nonalcoholic Fatty Liver Disease
Noninvasive Tests Used in Risk Stratification of Patients with Nonalcoholic Fatty Liver Disease
Current Treatment Options, Including Diet, Exercise, and Medications: The Impact on Histology
The Role Bariatric Surgery and Endobariatric Therapies in Nonalcoholic Steatohepatitis
Future Treatment Options and Regimens for Nonalcoholic Fatty Liver Disease
Special Population: Lean Nonalcoholic Fatty Liver Disease
Special Population: Pediatric Nonalcoholic Fatty Liver Disease
Economic Burden and Patient-Reported Outcomes of Nonalcoholic Fatty Liver Disease
Physicians' Use of Digital Health Interventions in the Management of Nonalcoholic fatty liver disease
Research Priorities for Precision Medicine in Nonalcoholic fatty liver disease